Alexander Spira
Virginia Cancer Specialists · Virginia Cancer Specialists Research Institute
Built from public records under this name as ClinicalTrials.gov spells it. A name can belong to more than one person, so each section says how its rows were tied to this name. No contact details are shown.
Trials
Studies that name Alexander Spira as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-11 23:50 UTC. Open this list on ClinicalTrials.gov
- Ph2NCT05673811 · Study of Nab-Paclitaxel and Gemcitabine and Plus/Minus VCN-01 in Patients With Metastatic Pancreatic CancerTheriva Biologics SL · completed · Pancreatic Adenocarcinoma, Metastatic · principal investigator
- Ph3NCT05211895 · A Global Study to Assess the Effects of Durvalumab + Domvanalimab Following Concurrent Chemoradiation in Participants With Stage III Unresectable NSCLCAstraZeneca · active not recruiting · Non-Small Cell Lung Cancer · principal investigator
Grants
NIH projects from RePORTER, fetched 2026-11-11 23:50 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. Coverage is US federal funding only; UK and EU funders are not searched yet.
No NIH project could be tied to this name by a shared trial or a matching institution.
Most cited trial papers
Clinical-trial papers with this author name, ranked by citations from NIH iCite, fetched 2026-11-11 23:50 UTC. The ranking covers the 200 most relevant of 147 PubMed records, and a shared surname and initials can bring in a namesake. All 147 on PubMed
- 2,386 citationsRCR 73.9
- Sotorasib for Lung Cancers with KRAS p.G12C Mutation.N Engl J Med · 20211,561 citationsRCR 84.2
- Adagrasib in Non-Small-Cell Lung Cancer Harboring a KRASG12C Mutation.N Engl J Med · 2022912 citationsRCR 57.5
- Brigatinib versus Crizotinib in ALK-Positive Non-Small-Cell Lung Cancer.N Engl J Med · 2018824 citationsRCR 27.7
- Perioperative Durvalumab for Resectable Non-Small-Cell Lung Cancer.N Engl J Med · 2023770 citationsRCR 62.8
- First-line gefitinib in patients with advanced non-small-cell lung cancer harboring somatic EGFR mutations.J Clin Oncol · 2008699 citationsRCR 14.1
- 660 citationsRCR 23.6
- Incidence and main causes of infertility in a resident population (1,850,000) of three French regions (1988-1989).Hum Reprod · 1991562 citationsRCR 21.4
- Amivantamab in EGFR Exon 20 Insertion-Mutated Non-Small-Cell Lung Cancer Progressing on Platinum Chemotherapy: Initial Results From the CHRYSALIS Phase I Study.J Clin Oncol · 2021562 citationsRCR 28.4
- Alectinib in Crizotinib-Refractory ALK-Rearranged Non-Small-Cell Lung Cancer: A Phase II Global Study.J Clin Oncol · 2016512 citationsRCR 16.3